Skip to main content

Table 2 Comparisons of the histological features between the MN and BN groups

From: Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study

 

Total patients

(n = 194)

BN group

(n = 107)

MN group

(n = 87)

P

Hyalinosis

1.09 ± 0.67

1.25 ± 0.57

0.90 ± 0.73

<0.001

Intimal fibrosis (n*)

1.74 ± 1.18(189)

1.79 ± 1.10(105)

1.68 ± 1.28(84)

0.52

Medial hypertrophy

0.69 ± 0.65

0.42 ± 0.55

1.01 ± 0.62

<0.001

Global glomerulosclerosis (%)

30(18–46)

32(18–45)

28(18–50)

0.63

Segmental glomerulosclerosis (%)

0(0–6)

0(0–5)

3(0–6)

0.04

Ischemic glomeruli (%)

8(0–22)

3(0–9)

20(8–30)

<0.001

TAIF (%)

30(20–60)

30(10–30)

60(40–70)

<0.001

  1. Data are presented as the medians (25th and 75th percentiles), the mean ± SD. n* is the available n for a given value. Where not specified, the available n is the same as the total number of cases in the top row
  2. BN, benign nephrosclerosis; MN, malignant nephrosclerosis; TAIF, tubular atrophy/interstitial fibrosis